Blood–retinal biomarker integration for precision prevention of Alzheimer’s disease: Lessons from retinal aging and the unfolded protein response
Open Access
- 28 February 2026
- journal article
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (11) , 5230-5231
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 10 references indexed in Scilit:
- Retinal biomarkers in cognitive impairment and dementia: Structural, functional, and molecular insightsAlzheimer's & Dementia, 2025
- Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegenerationAlzheimer's & Dementia, 2025
- Retinal manifestations and their diagnostic significance in Alzheimer's diseaseJournal of Alzheimer's Disease Reports, 2025
- Challenges in the practical implementation of blood biomarkers for Alzheimer’s diseaseThe Lancet Healthy Longevity, 2024
- Hyperspectral retinal imaging in Alzheimer’s disease and age-related macular degeneration: a reviewActa Neuropathologica Communications, 2024
- ER‐stress response in retinal Müller glia occurs significantly earlier than amyloid pathology in the Alzheimer's mouse brain and retinaGlia, 2024
- Emerging Roles of Extracellular Vesicles in Alzheimer’s Disease: Focus on Synaptic Dysfunction and Vesicle–Neuron InteractionCells, 2022
- Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer’s Disease Compared to MalesFrontiers in Cell and Developmental Biology, 2022
- Loss of XBP1 accelerates age-related decline in retinal function and neurodegenerationMolecular Neurodegeneration, 2018
- ER stress and the unfolded protein response in neurodegenerationNature Reviews Neurology, 2017